NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders
Funds Phase I trials for heart, lung, blood and sleep disorders — and pays for the final preclinical work needed to start one.
The National Heart, Lung, and Blood Institute funds investigator-initiated Phase I clinical trials of diagnostics and therapeutics for heart, lung, blood and sleep disorders, in adults and children.
What makes this route unusual is what it pays for besides the trial. The award covers final-stage preclinical activities needed to make the trial possible — stability studies, shipping studies, site t…
Investigator-initiated Phase I clinical trials of diagnostic and therapeutic interventions for heart, lung, blood and sleep disorders in adults and children, together with the final-stage preclinical activities directly required to start the trial. Two-phase, milestone-driven.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up